Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (201-210 of 292) with videos related to

Pageof 30
Sort By:
BJU International|September 11, 2024
The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancerKang Liu, Rossella Nicoletti, Hongda Zhao, et al.
European Urology|February 22, 2012
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgeryMichael Rink, Behfar Ehdaie, Eugene K Cha, et al.
Scientific Reports|July 15, 2025
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladderNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Urologic Oncology|April 4, 2020
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancerTill Eichenauer, Luca Simmendinger, Martina Kluth, et al.
BJU International|June 26, 2012
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
BJU International|February 22, 2012
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvisMarco Roscigno, Eugene K Cha, Michael Rink, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
BJU International|July 21, 2015
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation studyRomain Mathieu, Tobias Klatte, Ilaria Lucca, et al.
Urologic Oncology|October 23, 2017
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinomaGeorgios Gakis, Tina Schubert, Todd M Morgan, et al.
Pageof 30

Showing results (201-210 of 292) with videos related to

Sort By:
Pageof 30
BJU International|September 11, 2024
The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancerKang Liu, Rossella Nicoletti, Hongda Zhao, et al.
European Urology|February 22, 2012
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgeryMichael Rink, Behfar Ehdaie, Eugene K Cha, et al.
Scientific Reports|July 15, 2025
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladderNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Urologic Oncology|April 4, 2020
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancerTill Eichenauer, Luca Simmendinger, Martina Kluth, et al.
BJU International|June 26, 2012
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
BJU International|February 22, 2012
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvisMarco Roscigno, Eugene K Cha, Michael Rink, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
BJU International|July 21, 2015
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation studyRomain Mathieu, Tobias Klatte, Ilaria Lucca, et al.
Urologic Oncology|October 23, 2017
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinomaGeorgios Gakis, Tina Schubert, Todd M Morgan, et al.
Pageof 30